Enliven Therapeutics stock surges 28% on Merck-Terns deal
Go back to Enliven Therapeutics stock surges 28% on Merck-Terns deal| (NASDAQ: ELVN) | Delayed: 59.01 +1.15 (1.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.86 | 52 Week High | $ | |||
| Open | $58.36 | 52 Week Low | $ | |||
| Day High | $60.55 | P/E | N/A | |||
| Day Low | $57.36 | EPS | $ | |||
| Volume | 609,960 | |||||
| (NASDAQ: MAZE) | Delayed: 26.72 +0.19 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.53 | 52 Week High | $ | |||
| Open | $26.49 | 52 Week Low | $ | |||
| Day High | $27.44 | P/E | N/A | |||
| Day Low | $26.00 | EPS | $ | |||
| Volume | 440,599 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 151.64 +1.78 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.86 | 52 Week High | $65.46 | |||
| Open | $151.50 | 52 Week Low | $47.97 | |||
| Day High | $152.69 | P/E | 103.16 | |||
| Day Low | $149.97 | EPS | $1.47 | |||
| Volume | 8,171,242 | |||||

